New Leaf Venture Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

New Leaf Venture Partners’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,212	Closed	-$271K	–	21
2019 Q2	$271K	Hold	40,212	–	–	0.07%	21
2019 Q1	$330K	Hold	40,212	–	–	0.09%	20
2018 Q4	$643K	Hold	40,212	–	–	0.18%	20
2018 Q3	$1.33M	Hold	40,212	–	–	0.24%	20
2018 Q2	$909K	Sell	40,212 -56,240	-58%	-$1.33M	0.22%	15
2018 Q1	$2.8M	Hold	96,452	–	–	1.51%	11
2017 Q4	$2.69M	Sell	96,452 -137,615	-59%	-$4.27M	1.26%	13
2017 Q3	$8.54M	Sell	234,067 -75,000	-24%	-$2.32M	3.96%	8
2017 Q2	$6.86M	Sell	309,067 -100,000	-24%	-$787K	4.82%	7
2017 Q1	$2.41M	Buy	409,067 +150,000	+58%	+$1.08M	1.24%	11
2016 Q4	$1.4M	Hold	259,067	–	–	1%	10
2016 Q3	$2.31M	Hold	259,067	–	–	1.66%	10
2016 Q2	$2.49M	Buy	+259,067	New	+$2.5M	2.14%	10

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

New Leaf Venture Partners's AVEO Position: Q3 2019 in Review

New Leaf Venture Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2019, closing a stake of 40,212 shares — an estimated $271K sold.

New Leaf Venture Partners first reported a position in AVEO in Q2 2016 and held it in 13 quarters. The position peaked at $8.54M in Q3 2017. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.

New Leaf Venture Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
New Leaf Venture Partners sold 40,212 AVEO Pharmaceuticals, Inc. shares in Q3 2019, an estimated $271K.
New Leaf Venture Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2016 and held it in 13 quarters.
New Leaf Venture Partners's AVEO Pharmaceuticals, Inc. position peaked at $8.54M in Q3 2017.
59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2019.

Based on New Leaf Venture Partners's 13F filing for Q3 2019, filed 14 Nov 2019.